|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | |
| A61K 31/437 | |||
| A61P 25/00 | |||
| A61P 25/16 | |||
| A61P 25/18 | |||
| A61P 25/28 |
| (11) | Number of the document | 3478679 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17733044.6 |
| Date of filing the European patent application | 2017-06-15 | |
| (97) | Date of publication of the European application | 2019-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2017/053565 |
| Date | 2017-06-15 |
| (87) | Number | WO 2018/002760 |
| Date | 2018-01-04 |
| (30) | Number | Date | Country code |
| 201662357624 P | 2016-07-01 | US | |
| 201662372421 P | 2016-08-09 | US |
| (72) |
ZHANG, Lei, US
BUTLER, Christopher Ryan, US
BECK, Elizabeth Mary, GB
BRODNEY, Michael Aaron, US
BROWN, Matthew Frank, US
MCALLISTER, Laura Ann, US
LACHAPELLE, Erik Alphie, US
GILBERT, Adam Matthew, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | 5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES FOR TREATING NEUROLOGICAL AND NEURODEGENERATIVE DISEASES |
| 5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES FOR TREATING NEUROLOGICAL AND NEURODEGENERATIVE DISEASES |